Berlin, 21 October 2021 aap Implantate AG (“aap” or the “Company”) has successfully completed the capital increase with subscription rights resolved on 27 September 2021. The order book both for placed...
Top Health Care Business and Policy Leaders Enhance Position as One of the Leading Health Care Private Equity Firms NEW YORK--(BUSINESS WIRE)--Consonance Capital Partners, a leading U.S.-based healthcare private equity firm,...
This broadens the OsteoCentric portfolio and expedites the proliferation of its patented UnifiMI technology into the pelvis. AUSTIN, Texas, Oct. 20, 2021 /PRNewswire/ -- OsteoCentric Technologies, a pioneer of bone fixation in the...
European venture capital firm has raised €1 billion in the last 12 months across its expanding life science investment platform. PARIS--(BUSINESS WIRE)--Sofinnova Partners, a leading European life sciences venture capital firm...
Ganymed Robotics is one of 65 companies selected among over 2000 applicants by the European program EIC Accelerator.Funds will allow the company to accelerate the development of its next generation...
Perfecting the ‘real time’ characteristic of the DSG technologyProtection until 2035 PARIS & BOULDER, Colo.--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology...
Jonathon Singer brings more than three decades of financial and business strategy expertise to the growing orthopedic company. CARLSBAD, Calif., Oct. 15, 2021 /PRNewswire/ -- Breg, Inc., a leading orthopedic bracing and billing services...
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the pricing of its initial public...
SAN DIEGO, Oct. 14, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the launch of the...
BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corp. (NASDAQ: BBLG) (“Bone Biologics” or the “Company”), a developer of orthobiologic products for spine fusion markets, today announced the pricing of its underwritten public offering of...